Publications

Multiplexed LC–ESI–MRM‐MS‐based Assay for Identification of Coronary Artery Disease Biomarkers in Human Plasma

Featured on the back cover of Proteomics – Clinical Applications, Dr. Christoph Borchers’ newest publication focuses on the identification of biomarkers specific to coronary artery disease (CAD). Along with a group of BC scientists, including researchers from the University of Victoria and University of British Columbia, Dr. Borchers helped develop an LC-ESI-MS based assay that […]

Multiplexed LC–ESI–MRM‐MS‐based Assay for Identification of Coronary Artery Disease Biomarkers in Human Plasma Read More »

Publication spotlight: Metabolic Signatures of Cystic Fibrosis Identified in Dried Blood Spots For Newborn Screening Without Carrier Identification

Dr. Britz-McKibbin, one of TMICs core-scientists, and his team at McMaster University have discovered several new biomarkers from a single drop of blood that could allow earlier and more definitive detection of cystic fibrosis (CF), a genetic disease which strikes both children and adults, causing chronic problems with the digestive system and the lungs. The

Publication spotlight: Metabolic Signatures of Cystic Fibrosis Identified in Dried Blood Spots For Newborn Screening Without Carrier Identification Read More »

Scientists find simple urine test could offer a non-invasive approach for diagnosis of IBS patients

A recent study by TMIC’s Britz-McKibbin Research Group at McMaster University has identified new biomarkers for Irritable Bowel Syndrome (IBS) after comparing the metabolite profiles of urine samples from a cohort of IBS patients to a control group of healthy adults. Speaking on the study’s findings, lead author Dr. Philip Britz-McKibbin commented, “We were interested

Scientists find simple urine test could offer a non-invasive approach for diagnosis of IBS patients Read More »

Targeted Metabolomics and Covid-19

Targeted Metabolomics Identifies High Performing Diagnostic And Prognostic Biomarkers For Covid-19 When Dr. Yamile López-Hernández learned in early 2020 that the National Council of Science and Technology of Mexico (CONACYT) had issued a call for proposals for COVID-19-related research, one of the first people she reached out to was TMIC co-director Dr. David Wishart. While

Targeted Metabolomics and Covid-19 Read More »

Scroll to Top